![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Moberg pharma completes acquisition of dermoplast of prestige brands
Moberg Pharma AB has now completed the acquisition of DermoPlast® Prestige Brands, Inc. in accordance...
Global Drug Market Will Reach Nearly $1.5 Trillion in 2021
Total spending on medicines is forecast to reach $1.5 trillion by 2021, up 33 percent...
Novartis announces phase II SUSTAIN study of SEG101 significantly reduces frequency of sickle cell...
Results from the Phase II SUSTAIN study show that SEG101 (crizanlizumab, formerly SelG1), an anti-P-selectin...
Aegerion Pharmaceuticals INC and QLT INC Complete Merger Transaction ; QLT to Change Name...
Aegerion Pharmaceuticals Inc and QLT Inc announced the completion of their merger transaction, as a...
Catalent Acquires Accucaps To Expand Softgel Development And Manufacturing Capabilities And Capacity
Catalent Inc the leading global provider of advanced delivery technologies and development solutions for drugs,...
Arrow Generiques to acquire select assets in France from Teva
Arrow Generiques SAS, the French subsidiary of Aurobindo Pharma Ltd announced the signing of an...
GSK Starts Phase III Programme with Daprodustat for Anemia Associated with Chronic Kidney Disease
GlaxoSmithKline plc announced the start of a phase III development programme investigating daprodustat, an oral...
Lilly Announces Top-Line Results of Solanezumab Phase 3 Clinical Trial
Eli Lilly and Company announced that solanezumab did not meet the primary endpoint in the...
Sun Pharma to acquire Biosintez in Russia
Sun Pharma announced the execution of definitive agreements by its wholly owned subsidiary, for the...
Novartis acquires Selexys Pharmaceuticals Corporation and SelG1 antibody for reduction of pain crises in...
Novartis announced it has acquired Selexys Pharmaceuticals Corporation, a company specializing in development of therapeutics...